Mineralys Therapeutics Inc
Mineralys Therapeutics Inc’s latest rating changes from various analysts
Anna Perez
Mineralys Therapeutics Inc’s recently made public that its Officer Rodman David Malcom acquired Company’s shares for reported $9.38 million on ...
Mineralys Therapeutics Inc (MLYS) may enjoy gains as insiders got busy in the recent days
Roman Campbell
Mineralys Therapeutics Inc’s filing revealed that its Director Slingsby Brian Taylor unloaded Company’s shares for reported $43.35 million on Nov ...
The Potential Rise in the Price of Mineralys Therapeutics Inc (MLYS) following insiders activity
Roman Campbell
In a filing, Mineralys Therapeutics Inc revealed its Director Slingsby Brian Taylor unloaded Company’s shares for reported $43.35 million on ...
Understanding the Risks of Investing in Mineralys Therapeutics Inc (MLYS)
Daniel Torres
Mineralys Therapeutics Inc’s recent filing unveils that its Director Slingsby Brian Taylor unloaded Company’s shares for reported $43.35 million on ...
